SonoVascular, Inc.
Paul Dayton currently serves as Professor and Chair at the Joint Department of Biomedical Engineering at UNC and NC State since November 2019. Additionally, Paul holds positions as a Scientific Advisor for SonoVascular, Inc. and co-founder and Advisor for Triangle Biotechnology. With a background in biomedical engineering and medical devices, Paul has also provided consulting services to various companies since 2006. Previous roles include co-founding and serving as Scientific Advisor for SonoVol from 2012 to February 2022 and holding the position of Professor and Associate Chair at the University of North Carolina at Chapel Hill and North Carolina State University from 2007 to 2019. Earlier experience includes working as a Research Engineer at the University of California, Davis from 2001 to 2007. Paul earned a Ph.D. and a Master’s in Biomedical Engineering and Electrical Engineering, respectively, from the University of Virginia and holds a Bachelor of Science in Physics from Villanova University.
This person is not in any teams
SonoVascular, Inc.
SonoVascular has developed a novel pharmaco-mechanical ultrasound facilitated thrombectomy system, SonoThrombectomy™, that utilizes microbubble-mediated cavitation as a core enabling mechanism of action to remove blood clots more effectively. The system uniquely combines: (i) ultrasound, (ii) microbubbles, (iii) low dose thrombolytic drug, and (iv) mechanical retrieval and aspiration, delivered via an integrated intravascular catheter system. SonoVascular’s technology has been engineered to address and overcome the deficiencies and limitations of current interventional devices. Its design enables safe and effective treatment in the catheterization laboratory (cathlab), maximizes the reduction in clot burden, enhances the delivery and reduces the dose and duration of thrombolytics to levels that optimize safety and effectiveness, and eliminates the need for patients to be treated in the ICU.